C. H. Robinson Worldwide vs Expeditors International of Washington
CHRW and EXPD side by side, both in transportation services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CHRW and EXPD compare
Expeditors International of Washington is the larger company, worth 1.8 times as much as C. H. Robinson Worldwide ($25.8B against $14.6B).
On earnings, C. H. Robinson Worldwide is cheaper: it trades at 22.4× trailing earnings, against 28.9× for Expeditors International of Washington.
C. H. Robinson Worldwide grew revenue faster over the last twelve months (10.4% versus 6.8% for Expeditors International of Washington).
Expeditors International of Washington keeps more of each dollar of sales as profit, with a net margin of 7.6% compared with 3.7% at C. H. Robinson Worldwide.
Both pay dividends: C. H. Robinson Worldwide yields 2.0% and Expeditors International of Washington 0.79%.
C. H. Robinson Worldwide scores higher on the StockData Score (17 against 15 for Expeditors International of Washington), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CHRW | EXPD |
|---|---|---|
| Size and price | ||
| Market cap | $14.6B | $25.8B |
| Share price | $124.61 | $198.85 |
| Change, 1 year | −3.7% | 69.1% |
| Change, 5 years | 32.8% | 58.9% |
| Beta (5Y) | 0.67 | 0.85 |
| Employees | 12K | 20K |
| StockData Score | ||
| Total score | 17 (better) | 15 |
| Valuation score | 2 (better) | 0 |
| Growth score | 2 | 2 |
| Performance score | 6 (better) | 5 |
| Health score | 3 | 6 (better) |
| Dividend score | 4 (better) | 2 |
| Valuation | ||
| P/E | 22.4× (better) | 28.9× |
| P/S | 0.8× (better) | 2.1× |
| P/B | 9.2× (better) | 12.2× |
| EV/EBITDA | 16.5× (better) | 20.0× |
| P/FCF | 28.0× | 28.0× (better) |
| FCF yield | 3.6% | 3.6% (better) |
| Fair value | $112.08 | $126.10 |
| Margin of safety | −11.2% (better) | −57.7% |
| Growth | ||
| Revenue growth (TTM) | 10.4% (better) | 6.8% |
| Revenue growth, 5Y average | 0.03% | 2.9% (better) |
| Net income growth (TTM) | 11.5% (better) | 7.7% |
| EPS growth (TTM) | 13.0% (better) | 12.3% |
| EPS growth, 5Y average | 5.4% | 7.9% (better) |
| Profitability | ||
| Operating margin | 4.9% | 9.8% (better) |
| Net margin | 3.7% | 7.6% (better) |
| FCF margin | 2.9% | 7.7% (better) |
| Return on equity | 38.9% | 42.6% (better) |
| Return on invested capital | 23.4% | 83.7% (better) |
| Financial health | ||
| Debt / equity | 1.18 (better) | 0.00 |
| Net debt / EBITDA | 1.71 | – |
| Current ratio | 1.34 | 1.57 (better) |
| Altman Z-score | 6.72 | 9.22 (better) |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 2.0% (better) | 0.79% |
| Payout ratio | 45.4% | – |
| Years of dividend growth | 16 | 16 |
| Dividend growth, 5Y average | 4.1% | 8.2% (better) |
| Buyback yield | 5.2% (better) | 3.5% |
| Shareholder yield | 7.2% (better) | 4.3% |
| Ownership | ||
| Held by institutions | 106% | 98.6% |
| Held by insiders | 0.72% | 0.73% |
| Insider net buying, 12 months | −$18.4M | −$3.3M (better) |
| Short interest, % of float | 4.7% | 3.4% |
Go deeper
- CHRW stock overview
- CHRW income statement
- CHRW valuation and score
- EXPD stock overview
- EXPD income statement
- EXPD valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.